Updated Jul 16, 2026
Poole Sandra has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Sandra Poole appears in SEC filings associated with Travere Therapeutics, Inc. as of May 21, 2026. The provided context confirms an association with Travere Therapeutics but does not specify her exact title or role. Based on the SEC filing context, she is a professional connected to a public biotechnology company, suggesting experience in corporate governance, operations, or finance within or related to Travere Therapeutics. No additional, publicly verifiable biographical details are included in the given context.
| Role | Insider |
|---|---|
| Notability | 38/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-21 | TVTX | Travere Therapeutics, Inc. | A — Grant or award | 4.0K | $0.00 |
Sandra Poole appears in SEC filings associated with Travere Therapeutics, Inc. as of May 21, 2026. The provided context confirms an association with Travere Therapeutics but does not specify her exact title or role. Based on the SEC filing context, she is a professional connected to a public biotechnology company, suggesting experience in corporate governance, operations, or fi…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Poole Sandra profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.